Principal Securities’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-441
Closed -$27.6K 2208
2025
Q3
$27.6K Buy
441
+14
+3% +$762 ﹤0.01% 2249
2025
Q2
$22.2K Buy
427
+115
+37% +$5.14K ﹤0.01% 2261
2025
Q1
$9.53K Hold
312
﹤0.01% 2546
2024
Q4
$9.53K Buy
312
+56
+22% +$1.57K ﹤0.01% 2541
2024
Q3
$5.87K Buy
256
+102
+66% +$2.89K ﹤0.01% 2622
2024
Q2
$4.45K Buy
154
+22
+17% +$512 ﹤0.01% 2680
2024
Q1
$2.72K Sell
132
-34
-20% -$729 ﹤0.01% 2783
2023
Q4
$4.49K Buy
+166
New +$4.35K ﹤0.01% 2565

Other funds holding GH

Principal Securities's GH Position: Q4 2025 in Review

Principal Securities sold out of Guardant Health (GH) in Q4 2025, closing a stake of 441 shares — an estimated $27.6K sold.

Principal Securities first reported a position in GH in Q4 2023 and held it in 8 quarters. The position peaked at $27.6K in Q3 2025. 495 funds tracked by Wall St. Rank hold GH as of Q4 2025.

  • Principal Securities reported no remaining Guardant Health position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 441 Guardant Health shares in Q4 2025, an estimated $27.6K.
  • Principal Securities first reported a position in Guardant Health in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Guardant Health position peaked at $27.6K in Q3 2025.
  • 495 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.